ArticleJournal of Korean medical science2026
Epidemiological Trends of Herpes Zoster in Korea, 2010-2022: A Nationwide Study Using National Health Insurance Data.
Article in Journal of Korean medical science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Impact of varicella vaccination on the epidemiology of herpes zoster and postherpetic neuralgia: a narrative review.Journal of Yeungnam medical science · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Herpes zoster (HZ) poses a growing public health burden, particularly in aging populations. This study investigated long-term trends in the incidence, hospitalization, and recurrence of HZ in Korea. We analyzed National Health Insurance Service data covering adults aged ≥ 20 years from 2010 to 2022. HZ cases were defined using International Classification of Diseases-10 codes and antiviral treatment criteria. Rates were stratified by age, sex, and income level. The incidence of HZ increased until 2018 and then stabilized. Women and older adults consistently showed higher incidence, hospitalization, and recurrence rates. The medical aid beneficiaries had significantly higher hospitalization rates. Despite recent stabilization, the burden of HZ remains substantial among older adults, women, and medical aid beneficiaries. Targeted vaccination and ongoing surveillance are essential to mitigate disease burden and reduce disparities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.